Impatient with years of inaction in Washington on prescription drug prices, U.S. hospital groups, startups and nonprofits have started making their own medicines. Their aim is to combat stubbornly high prices and persistent shortages of drugs with little competition. The efforts are at varying stages, but some have already shipped millions of doses. Nearly half